Management of undifferentiated thyroid cancer
- 1 December 2000
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 14 (4) , 615-629
- https://doi.org/10.1053/beem.2000.0106
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Semi-quantitative comparison of the differentiation markers and sodium iodide symporter messenger ribonucleic acids in papillary thyroid carcinomas using RT-PCRActa Endocrinologica, 2000
- N-cadherin-mediated adhesion and aberrant catenin expression in anaplastic thyroid-carcinoma cell linesInternational Journal of Cancer, 1999
- Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolismActa Endocrinologica, 1999
- An Immunohistochemical Study of Na+/I−Symporter in Human Thyroid Tissues and Salivary Gland TissuesEndocrinology, 1998
- Desensitization in Normal and Neoplastic Human Thyroid Cell LinesWorld Journal of Surgery, 1998
- Iodide Uptake and Experimental 131I Therapy in Transplanted Undifferentiated Thyroid Cancer Cells Expressing the Na+/I− Symporter GeneEndocrinology, 1997
- Relationship between prognostic score and thyrotropin receptor (TSH-R) in papillary thyroid carcinoma: immunohistochemical detection of TSH-RBritish Journal of Cancer, 1997
- Quantitative and qualitative differences in growth, invasion and lung colonization of an anaplastic and a papillary human thyroid cancer cell linein vitro andin vivoClinical & Experimental Metastasis, 1996
- Na(+)-I- symport activity is present in membrane vesicles from thyrotropin-deprived non-I(-)-transporting cultured thyroid cells.Proceedings of the National Academy of Sciences, 1994
- Peroxidase and Coupling Activities of Thyroid Peroxidase in Benign and Malignant Thyroid Tumor TissuesThyroid®, 1992